The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine Rosalind A. GrahamJ. M. BurchellJ. Taylor-Papadimitriou REVIEW Pages: 71 - 80
Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A Jan FagerbergPeter RagnhammarJ. Fagersberg ORIGINAL ARTICLE Pages: 81 - 87
Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2 James D. PancookJürgen C. BeckerR. A. Reisfeld ORIGINAL ARTICLE Pages: 88 - 92
Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion Ursula Elsässer-BeileUlrich WetterauerSabine von Kleist ORIGINAL ARTICLE Pages: 93 - 98
Interferon γ (IFNγ) gene transfer of an EMT6 tumor that is poorly responsive to IFNγ stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC Monica C. PanelliE. WangE. T. Akporiaye ORIGINAL ARTICLE Pages: 99 - 107
In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425 R. Senekowitsch-SchmidtkeKurt SteinerRegine Truckenbrodt ORIGINAL ARTICLE Pages: 108 - 114
Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells M. G. RosenblumLawrence CheungJames L. Murray ORIGINAL ARTICLE Pages: 115 - 121
Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2 Gernot ZisselWalter E. AulitzkyJ. Müller-Quernheim ORIGINAL ARTICLE Pages: 122 - 126
Combination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinoma T. HimotoSeishiro WatanabeMotoo Saito ORIGINAL ARTICLE Pages: 127 - 131
